Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer
2 意见
• 07/14/23
0
0
嵌入
Experts discuss the next-generation ALK inhibitors ceritinib and AP26113 as treatments for patients with non-small cell lung cancer.
For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论